NOT-CA-20-013: Notice of Change to the Advisory Council Review dates for PAR-20-052, NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)

Notice of Change to the Advisory Council Review dates for PAR-20-052, NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)

Notice Number:

NOT-CA-20-013

Key Dates

Release Date:

November 22, 2019

Related Announcements

PAR-20-052

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform interested applicants of a change to the Advisory Council Review dates for PAR-20-052, "NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)". AIDS applications submitted for the January 7, 2020 due date will be assigned to May 2020 Advisory Council Review.

This Funding Opportunity Announcement has been modified to add the following Advisory Council Review date (in italics).

Part 1. Overview Information, Key Dates

Currently reads:

Advisory Council Review: October 2020; January 2021; May 2021; October 2021; January 2022; May 2022;; October 2022; January 2023; May 2023

Modified to read (in italics)

Advisory Council Review: May 2020 (AIDS only) ; October 2020; January 2021; May 2021; October 2021; January 2022; May 2022;; October 2022; January 2023; May 2023

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov